NIH-funded research U01 cooperative agreement

Restoring awareness of low blood sugar in type 1 diabetes

Official title: Restoring awareness of hypoglycemia in type 1 diabetes

Funded at University of Pennsylvania · NIH-11319767 · Data updated 2026-11-12

This project tests whether education, hybrid closed-loop insulin pumps, and small doses of glucagon can help adults with long-standing type 1 diabetes regain warning signs of low blood sugar.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 25, 2022
Project endDecember 31, 2027
Funding year2026
Award (this year)$731,968
NIH project number5U01DK135120-04
Project IDNIH-11319767 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) with long-standing type 1 diabetes who have impaired awareness of hypoglycemia or frequent problematic low blood sugars are the intended candidates.

Less likely to help

People who already notice low-blood-sugar symptoms normally, have type 2 diabetes, or cannot use closed-loop devices or glucagon for medical reasons are unlikely to benefit from this specific program.

What this research studies

Over 24 months you'll take part in an adaptive randomized program where your assigned treatment can change based on how you respond. Options include standard hypoglycemia-avoidance education, using an automated hybrid closed-loop insulin delivery system, and taking mini-doses of glucagon. Researchers will measure hormonal and symptom responses using controlled low-blood-sugar tests (hypoglycemic clamps) and track your real-world glucose data to see which approaches restore warning signs. The goal is to learn which people benefit from which treatments so dangerous lows can be prevented more reliably.

Why it matters

Potential benefit: If successful, this work could lower the risk of severe low-blood-sugar episodes and make tighter blood-sugar control safer for people with type 1 diabetes.

How similar studies have gone: Previous studies show education and automated insulin delivery can reduce hypoglycemia, but combining an adaptive trial with mini-dose glucagon and detailed clamp testing to restore physiological warning responses is relatively new.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Rickels, Michael R — University of Pennsylvania
  • Study coordinator: Rickels, Michael R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.